Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Great Britain’s leading academic institution, the Royal Society, has joined with 67 other national academies to urge the United Nations to ban cloning babies but permit using the technology for medical research, according to The Scotsman.

The United States is pressing the UN for an international ban on all forms of human cloning. Such a ban could be introduced at the UN’s general session in October. Member nations would not be compelled to agree to the ban, but scientists fear such a treaty would place a major obstacle in the way of vital stem cell research, which could help biologists studying diseases such as diabetes, Parkinson’s, Alzheimer’s, and cancer–perhaps one day even leading to cures.

Researchers outside the U.S. have already created cells via human cloning; South Koreans published the first evidence of cloned embryonic stem cells last year, and in August, the British government granted scientists from the University of Newcastle a license to clone human embryos for medical research.

A big concern is that banning all forms of human cloning will drive maverick cloners underground, away from serious attempts to regulate the research.

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me